12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers Kineta (NASDAQ:KA) shares moved upwards by 28.5% to $0.67 during Friday’s after-market session. The company’s market cap…
Why Skye Bioscience Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday’s Mid-Day Session
Shares of Skye Bioscience, Inc. (NASDAQ:SKYE) fell sharply during Monday’s session after the company announced its SBI-100 Ophthalmic…
12 Health Care Stocks Moving In Monday’s Intraday Session
Gainers Seres Therapeutics (NASDAQ:MCRB) stock moved upwards by 34.0% to $0.82 during Monday’s regular session. The company’s market…
12 Health Care Stocks Moving In Thursday’s Intraday Session
Gainers OneMedNet (NASDAQ:ONMD) shares moved upwards by 118.4% to $1.07 during Thursday’s regular session. The market value of…
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The…
RenovaroCube, Wholly Owned Subsidiary Of Renovaro, Unveils Flamingo, A Multi-Cancer Detection Model Contributing To Its Mission To Transform Early Cancer Diagnostics
RenovaroCube, wholly owned subsidiary of Renovaro, Inc. (NASDAQ:RENB), a company at the forefront of AI-driven healthcare innovation, proudly unveils Flamingo, a potentially groundbreaking multi-cancer detection model
RenovaroCube To Acquire 100% Ownership Of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership; Financial Terms Not Disclosed
Renovaro Inc. (NASDAQ:RENB), a trailblazer in AI-driven early cancer diagnostics and therapeutics, and Cyclomics, a leader in ultra-sensitive 4th generation multi-omics molecular biology, proudly announce a significant
Renovaro Announces The Appointment Of Professor Dr. Geert Kazemier As The Chairman Of Its Scientific Advisory Board
Renovaro Inc. (NASDAQ:RENB), a pioneer in cancer diagnostics and therapeutics powered by artificial intelligence, announces the distinguished Professor Geert Kazemier, MD, PhD, as the new Chairman of its Scientific
Hit With Short Seller Report, Renovaro Biosciences Comments On Hindenburg’s Opinion Piece
Renovaro Biosciences confronts Hindenburg's short report fallout, highlighting tech and business leaders joining the board. Despite false claims, the company asserts confidence.
Renovaro Biosciences Responds To Hindenburg’s Recent Opinion Piece, Says “The Board And Management Remain Confident In The Future Of The Company And Believe People Will See These Baseless Attacks For What They Are.”
The following is a statement by Renovaro (NASDAQ:RENB) in response to Hindenburg's recent opinion piece:We felt compelled to comment on the shorter Hindenburg's opinion piece.The one thing Hindenburg got right is that